+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Elucidating the Molecular Basis for Inhibitory Neurotransmission Regulation by Artemisinins



Elucidating the Molecular Basis for Inhibitory Neurotransmission Regulation by Artemisinins



Neuron 2019



The frontline anti-malarial drug artemisinin and its derivatives have also been implicated in modulating multiple mammalian cellular pathways, including the recent identification of targeting γ-aminobutyric acid type A receptor (GABAAR) signaling in the pancreas. Their molecular mechanism of action, however, remains elusive. Here, we present crystal structures of gephyrin, the central organizer at inhibitory postsynapses, in complex with artesunate and artemether at 1.5-Å resolution. These artemisinins target the universal inhibitory neurotransmitter receptor-binding epitope of gephyrin, thus inhibiting critical interactions between gephyrin and glycine receptors (GlyRs) as well as GABAARs. Electrophysiological recordings reveal a significant inhibition of gephyrin-mediated neurotransmission by artemisinins. Furthermore, clustering analyses in primary neurons demonstrate a rapid inhibition and a time-dependent regulation of gephyrin and GABAAR cluster parameters. Our data not only provide a comprehensive model for artemisinin-mediated modulation of inhibitory neurotransmission but also establish artemisinins as potential lead compounds to pharmacologically interfere with this process.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 066446966

Download citation: RISBibTeXText

PMID: 30704910

DOI: 10.1016/j.neuron.2019.01.001


Related references

Elucidating the molecular basis of PKA regulation of the cloned equivalent of the smooth muscle KATP channel. Biophysical Journal 86(1): 127a, January, 2004

Progress in elucidating the molecular basis of the host plant - Aspergillus flavus interaction: a basis for devising strategies to reduce aflatoxin contamination in crops. Aflatoxin and food safety: 167-193, 2005

Progress in elucidating the molecular basis of the host plant-Aspergillus flavus interaction, a basis for devising strategies to reduce aflatoxin contamination in crops. Journal of Toxicology, Toxin Reviews 23(2/3): 345-380, 2004

Progress in elucidating the molecular basis of the host plant - Aspergillus flavus interaction, a basis for devising strategies to reduce aflatoxin contamination in crops. Journal of Toxicology-Toxin Reviews 23(2-3): 345-380, 2004

Elucidating the molecular genetic basis of the corneal dystrophies: are we there yet?. Archives of Ophthalmology 125(2): 177-186, 2007

Elucidating the molecular basis of triallelism in Bardet-Biedl syndrome. European Journal of Human Genetics 10(Supplement 1): 253, 2002

The molecular basis of neurotransmission at the muscarinic receptor. Biochemical Pharmacology 30(21): 2887-2891, 1981

Colors with functions: elucidating the biochemical and molecular basis of carotenoid metabolism. Annual Review of Nutrition 30: 35-56, 2010

A co-module approach for elucidating drug-disease associations and revealing their molecular basis. Bioinformatics 28(7): 955-961, 2012

The challenges involved in elucidating the molecular basis of sperm-egg recognition in mammals and approaches to overcome them. Cell and Tissue Research 363(1): 227-235, 2016

Endothelial cell interactions with Plasmodium falciparum Elucidating the molecular basis for cerebral malaria. Program & Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 33(0): 440, 1993

Elucidating the molecular basis of MSH2-deficient tumors by combined germline and somatic analysis. International Journal of Cancer 141(7): 1365-1380, 2017

Structural comparison of psychrophilic and mesophilic trypsins: Elucidating the molecular basis of cold-adaptation. European Journal of Biochemistry 267(4): 1039-1049, 2000

A new molecular basis for neurotransmission and ion channel gating including the chemical identity of anesthetic receptors neurotransmitter receptors endogenous molecular gates. Szantay, C. Chemistry And Biotechnology Of Biologically Active Natural Products; Fourth International Conference, Budapest, Hungary, August 10-14, . Xi 402p. Akademiai Kiado: Budapest, Hungary. Illus. 265-268, 1988

Cystic fibrosis: A brief look at some highlights of a decade of research focused on elucidating and correcting the molecular basis of the disease. Journal of Bioenergetics & Biomembranes 33(6): 513-521, December, 2001